Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
about
Objective assessment of facial lipoatrophy changes in a cohort of HIV-infected patients taking combination antiretroviral therapy.Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients.Strategies for treating HIV-related lipodystrophy.A longitudinal evaluation of the impact of a polylactic acid injection therapy on health related quality of life amongst HIV patients treated with anti-retroviral agents under real conditions of useA qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individualsPharmacologic therapy for HIV-associated lipodystrophy.HIV revisited: the global impact of the HIV/AIDS epidemic.Clinical utility of current NNRTIs and perspectives of new agents in this class under development.HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection.Treatment options for lipodystrophy in HIV-positive patients.Alcohol consumption and lipodystrophy in HIV-infected adults with alcohol problems.The association of self-perception of body fat changes and quality of life in the Women's Interagency HIV Study.HIV-Associated Facial Lipodystrophy: Experience of a Tertiary Referral Center With Fat and Dermis-Fat Compound Graft Transfer.A randomized clinical trial to evaluate the effect of diet on weight loss and coping of people living with HIV and lipodystrophy.Treatment of facial lipoatrophy with polymethylmethacrylate among patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): impact on the quality of life.Lipodystrophy in a cohort of human immunodeficiency virus-infected Asian patients: prevalence, associated factors, and psychological impact.Changes in body fat measured by DEXA in patients taking different formulations of stavudine.The impact of facial lipoatrophy treatment with polymethyl methacrylate in AIDS patients as measured by four quality-of-life questionnaires.Cost consequences of HIV-associated lipoatrophy.Multidisciplinary Approach to the Treatment of Metabolic and Morphologic Alterations of HIV-Related Lipodystrophy
P2860
Q33407077-A967B3A6-B1E5-47E3-AFC4-8BA1A8756F24Q34161671-D9D7BD69-9E95-40ED-B2C9-E1F98305F9EBQ34481623-AD2A7E47-8A2C-4AF6-99A2-51C47C3D8D0AQ34593181-033640B6-F874-42BB-9B17-08A4D23A42D5Q35530469-B0067913-FC9B-41E6-9A56-ED5106A8469DQ35644854-C84F7D18-F4A1-44A6-8F75-9A76893BAD45Q35767480-36CE0C0D-B912-4AB2-A4EF-70E8ACED9EC4Q35842270-6FB14063-A3ED-4E6A-B1E9-B3B34A1FACAAQ36007239-EC5DD365-267D-45BD-B4D8-1A6CC058BE5EQ36739802-D320F610-8ABA-40EC-A186-672C2DDC683CQ37030842-8513DB36-B8F4-44F7-86E5-C7A10AE15C0BQ37082957-77FBACA9-2374-4195-8C4F-6587EF9ECED8Q37161445-BEF2734A-0418-4568-A40C-C8A8BF201F22Q37601992-25CE3AA5-4362-419F-8A9C-D75B6F0E4BE1Q40201509-DEB9479E-DCCA-41DA-8400-4378DAED7003Q42233375-CE59BDFC-2BFD-4DF0-A27C-28E9A66A9193Q44143973-A034AA09-B0C9-4A1B-B14E-12E0086AE48EQ46923102-040FE493-99F9-4D36-A069-5985E6249E33Q48569795-12A87A4E-D7F8-43D3-A853-349377CD0F78Q53508863-5CFC60EE-FC9A-452C-9E6F-91EF09DD98B4Q58798126-BA0363BE-C5FD-4DF3-8C5C-107D135AB2DF
P2860
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
@ast
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
@en
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
@nl
type
label
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
@ast
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
@en
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
@nl
prefLabel
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
@ast
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
@en
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
@nl
P2093
P1433
P1476
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
@en
P2093
E Martínez
J M Gatell
M A Garcia-Viejo
P304
P356
10.2165/00002018-200124030-00001
P577
2001-01-01T00:00:00Z
P6179
1023554792